metformin/Finding
One finding, on its own
A single claim from the graph, with the evidence strength computed from its study, the sentence it was drawn from, and the paper. This address does not change.
metformin — decreases oesophageal cancer incidence
Evidence strength: moderate.Finding“The random effects model showed that compared with the control groups, metformin might decrease EC incidence (OR = 0.87, P = 0.04).”
Quoted verbatim from Association of metformin use with risk and survival outcome of esophageal cancer in patients with diabetes: A systematic review and meta-analysis.. - Study
- meta-analysis
- Population
- Patients with diabetes; 12 observational studies (cohort and case-control) of metformin use versus non-use, pooled incidence of esophageal cancer
Effect 0.87 odds ratio
Association of metformin use with risk and survival outcome of esophageal cancer in patients with diabetes: A systematic review and meta-analysis.2025PMID:3977482910.1371/journal.pone.0310687Permalink
To cite this finding: https://catalystproject.ai/e/01M5JDWTD7MCGD8A760ZHPXB2V